Primary amyloidosis epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are approximately 4000 new cases of AL amyloidosis annually in the United States, though actual incidence may be somewhat higher as a result of under-diagnosis. While the incidence is thought to be equal in males and females, about 60% of patients referred to amyloid centers are male. AL amyloidosis has been reported in individuals as young as 20 years of age but is typically diagnosed at about age 50-65. | There are approximately 4000 new cases of AL amyloidosis annually in the United States, though actual [[incidence]] may be somewhat higher as a result of under-diagnosis. While the [[incidence]] is thought to be equal in males and females, about 60% of patients referred to amyloid centers are male. AL amyloidosis has been reported in individuals as young as 20 years of age but is typically diagnosed at about age 50-65. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
=== Prevalence === | |||
=== Incidence === | |||
=== Gender === | |||
=== Race === | |||
Revision as of 17:34, 30 October 2019
Primary amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Primary amyloidosis epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Primary amyloidosis epidemiology and demographics |
Primary amyloidosis epidemiology and demographics in the news |
Risk calculators and risk factors for Primary amyloidosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
There are approximately 4000 new cases of AL amyloidosis annually in the United States, though actual incidence may be somewhat higher as a result of under-diagnosis. While the incidence is thought to be equal in males and females, about 60% of patients referred to amyloid centers are male. AL amyloidosis has been reported in individuals as young as 20 years of age but is typically diagnosed at about age 50-65.